An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is hindered by its production ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

▎药明康德内容团队编辑  近年来，mRNA疫苗已经成为人类对抗疾病的全新工具。在COVID-19疫情期间，mRNA疫苗首次问世，为很多人带来了保护。2023年，诺贝尔生理学或医学奖也授予了mRNA疫苗领域的两位先驱——Katalin ...

每经AI快讯，有投资者在投资者互动平台提问：尊敬的徐总梁董秘，今年由两位miRNA领域科学家分享2024年诺贝尔生理学或医学奖，请问贵司在这方面是否有布局或者技术储备。

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Current cancer treatments typically include surgery, chemotherapy, radiotherapy, and immunotherapy. However, these approaches ...